XML 21 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Shares
Additional paid-in capital
Accumulated deficit
Accumulated Other Comprehensive (Loss) Income
Non- Controlling Interests
Beginning balance (in shares) at Sep. 30, 2022   25,598,289        
Beginning balance at Sep. 30, 2022 $ 359,766 $ 6,362 $ 707,787 $ (348,277) $ (5,500) $ (606)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Consolidated net loss (105,140)     (104,902)   (238)
Noncontrolling interest (292)         (292)
Issuance of stock under employee stock plans (in shares)   178,880        
Issuance of stock under employee stock plans 109 $ 44 65      
Stock based compensation 7,844   7,844      
Actuarial loss (net of tax) (28)       (28)  
Foreign currency translation adjustment 5,315       5,315  
Cumulative currency translation realized through sale of subsidiary 762       762  
Other 154     (99) (219) 472
Ending balance (in shares) at Sep. 30, 2023   25,777,169        
Ending balance at Sep. 30, 2023 268,490 $ 6,406 715,696 (453,278) 330 (664)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Consolidated net loss (108,445)     (108,885)   440
Noncontrolling interest (2,085)   (2,309)     224
Issuance of stock under employee stock plans (in shares)   237,960        
Issuance of stock under employee stock plans 11 $ 60 (49)      
Stock based compensation 6,740   6,740      
Actuarial loss (net of tax) 0          
Pension cost amortization 188       188  
Foreign currency translation adjustment 894       894  
Cumulative currency translation realized through sale of subsidiary 0          
Other (57)   (57)      
Warrants issued in connection with Purchase Agreement $ 4,768   4,768      
Ending balance (in shares) at Sep. 30, 2024 26,015,129 26,015,129        
Ending balance at Sep. 30, 2024 $ 170,504 $ 6,466 724,789 (562,163) 1,412 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Consolidated net loss (68,625)     (68,625)    
Issuance of common shares (in shares)   6,900,000        
Issuance of common shares 27,524 $ 1,725 25,799      
Issuance of stock under employee stock plans (in shares)   641,109        
Issuance of stock under employee stock plans 31 $ 160 (129)      
Stock based compensation 6,028   6,028      
Actuarial loss (net of tax) 578       578  
Pension cost amortization 279       279  
Foreign currency translation adjustment (41)       (41)  
Cumulative currency translation realized through sale of subsidiary 0          
Other (in shares)   801,013        
Other $ (250) $ 200 (425) (25)    
Ending balance (in shares) at Sep. 30, 2025 34,357,251 34,357,251        
Ending balance at Sep. 30, 2025 $ 136,028 $ 8,551 $ 756,062 $ (630,813) $ 2,228 $ 0